维普中文期刊产品整合服务

Lamivudine treatment enabling right hepatectomy for hepatocellular carcinoma in decompensated cirrhosis

查看全文 作  者:Koichi [1]Honda;Masataka [1]Seike;Shin-ichiro [2]Maehara;Koichiro [2]Tahara;Hideaki [2]Anai;Akira [3]Moriuchi;Toyokichi [4]Muro 高影响力作者 机构地区:[1]First Department of Internal Medicine,Oita University,Oita 879-5593,Japan;[2]Department of Surgery,National Hospital Organization Oita Medical Center,Oita 870-0263,Japan;[3]Department of Pathology,National Hospital Organization Oita Medical Center,Oita 870-0263,Japan;[4]Department of Gastroenterology and Hepatology,National Hospital Organization Oita Medical Center,Oita 870-0263,Japan高影响力机构 出  处:《World Journal of Gastroenterology》索引2012年第18卷第20期,共5页高影响力期刊 摘  要:A 69-year-old man was admitted to our hospital in October 2003,for further examination of two liver tumors.He was diagnosed with hepatocellular carcinoma(HCC) arising from decompensated hepatitis B virus(HBV)-related cirrhosis.Long-term lamivudine administration improved liver function dramatically despite repeated treatment for HCC.His Child-Pugh score was 9 points at start of lamivudine treatment,improving to 5 points after 1 year.His indocyanine green at 15 min after injection test score was 48%before lamivudine treat-ment,improving to 22%after 2 years and to 5%after 4 years.Radiofrequency ablation controlled the HCC foci and maintained his liver function.In April 2009,abdominal computed tomography revealed a tumor thrombus in the right portal vein.Since his indocyanine green test results had improved to less than 10%,we performed a right hepatectomy,which was successful.To our knowledge,there have been no documented reports of patients undergoing successful right hepatectomy for HCC arising from decompensated cirrhosis.The findings observed in our patient indicate the importance of nucleoside analogs for treating HBV-related HCC. 关 键 词:拉米夫定 肝硬化 治疗 肝癌 乙型肝炎病毒 核苷类似物 射频消融 肝肿瘤
相关文献

参考文献(34)

引证文献(7)

耦合文献(15)

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费